Dr. Steven Timothy Popper, MD

Dr. Popper practices at Palomar Corporate Health Services - HOPD in Escondido, California.

Dr. Popper's NPI, 1679849012, was assigned on March 30, 2012. Dr. Popper graduated from UCSF School of Medicine in 2012. Dr. Popper holds California license A130275.

Dr. Popper's primary practice is Palomar Corporate Health Services - HOPD, at 2125 Citracado Pkwy, Escondido, CA 92029.

Dr. Popper's primary practice is Palomar Corporate Health Services - HOPD in Escondido, California. Dr. Popper is also affiliated with Palomar Medical Center Downtown Escondido. The medical group on file is Palomar Health Medical Group. Dmand AI also links Dr. Popper to 1 more hospital, 4 medical groups and 2 group practices and clinics, each named with a free account. Dr. Popper's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Popper practices, 5 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Popper's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Popper is board certified in critical care medicine by the American Board of Internal Medicine. Dr. Popper is licensed in California.

Dmand AI lists acute respiratory failure, asthma, chronic lung disease, chronic obstructive pulmonary disease (COPD), chronic respiratory failure, pleural effusion, pneumonia and pulmonary fibrosis among the conditions Dr. Popper treats.

CMS data shows 988 Medicare services from Dr. Popper across 13 procedure codes in 2024, for 371 Medicare patients. Medicare paid $79,250 for them.

CMS counts 371 Medicare patients who saw Dr. Popper in 2024. The largest group is 75 to 84, with 144 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 25% are also on Medicaid. Their average risk score is 2.18, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Popper's median patient age at 74, with 55% women.

In 2024, Dr. Popper wrote 2,001 Medicare Part D claims for 322 patients. 33% of them were for generic drugs. CMS names the drug for 1,834 of them, across 35 drugs with 11 or more claims each, at $1,443,215 in total drug cost. In 2023, CMS named 1,685 claims across 32 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 19 out of 100 for Dr. Popper for performance year 2024, reported individually. Dr. Popper accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Popper as offering telehealth.

CMS Open Payments shows 63 general payments to Dr. Popper from 17 drug and device companies from 2018 to 2025. Education make up the largest share, 70% of the total. Intuitive Surgical, Inc. paid the most, $3,261.

Dr. Popper graduated from UCSF School of Medicine in 2012.

Dr. Popper is in network with 11 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.